Image Analysis Group

Uncertainties & Opportunities: BioPharma in the Era of Covid19 Bio-Pharma Crisis & Opportunities in the Era of Covid As Crunchbase reports that ‘in 2009, one-third fewer start-ups raised early-stage funding,’ we already see investors advising biotechs to plan for two years without raising new funding. Is this the right advice in today’s situation? Should ...